Gilead Sciences, Inc. 13D and 13G filings for Sierra Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 4:55 pm Purchase |
2021-12-31 | 13G | Sierra Oncology, Inc. SRRA |
GILEAD SCIENCES INC GILD |
1,450,566 9.200% |
377,266 (+35.15%) |
Filing |